Gene | Input weight | Standard | Rank | |
MEF2C | 0.25 | 1 | 248 | |
AKT1 | 0.25 | 1 | 303 | |
HRK | - | - | 1059 | |
CDH13 | - | - | 1072 | |
ESR1 | 0.25 | 1 | 1914 | |
FOXA1 | - | - | 2277 | |
IL3 | - | - | 2778 | |
STAT5B | - | - | 3888 | |
NKX2-5 | 0.25 | 1 | 5490 | |
TGFBR1 | - | -1 | 6027 | |
BNIP3 | - | - | 6611 | |
BCL2L1 | - | - | 7198 | |
PTPRJ | - | -1 | 7218 | |
BAX | - | - | 7313 | |
BNIP3L | - | - | 12178 | |
AKT1S1 | - | - | 12840 | |
STAT5A | - | - | 19316 | |
IL2RB | - | - | 20992 | |
SNAI2 | - | -1 | 22934 | |
SPDEF | - | - | 23955 | |
SKP2 | - | - | 25453 |
GO:0045884
Name | Description | External IDs |
MEF2C | myocyte enhancer factor 2C | Entrez:4208  HGNC: 6996  Ensembl: ENSG00000081189  HPRD: 02809  |
AKT1 | v-akt murine thymoma viral oncogene homolog 1 | Entrez:207  HPRD: 01261  Ensembl: ENSG00000142208  HGNC: 391  |
HRK | harakiri, BCL2 interacting protein (contains only BH3 domain) | Entrez:8739  HGNC: 5185  HPRD: 04581  |
CDH13 | cadherin 13 | Entrez:1012  Ensembl: ENSG00000140945  HGNC: 1753  HPRD: 03219  |
ESR1 | estrogen receptor 1 | Entrez:2099  HGNC: 3467  HPRD: 00589  Ensembl: ENSG00000091831  |
Geneset | Type | Freq. (Network vs Genome) | P-Value (FDR Corrected) | Genes |
Gene | Description | Avg. edge score to query | Rank | In geneset | In query |
MEF2C | myocyte enhancer factor 2C | ||||
AKT1 | v-akt murine thymoma viral oncogene homolog 1 | ||||
HRK | harakiri, BCL2 interacting protein (contains only BH3 domain) | ||||
CDH13 | cadherin 13 | ||||
ESR1 | estrogen receptor 1 |
Query gene | Gene | Gene description | Edge score |
MEF2C | MEF2C | myocyte enhancer factor 2C | |
AKT1 | AKT1 | v-akt murine thymoma viral oncogene homolog 1 | |
HRK | HRK | harakiri, BCL2 interacting protein (contains only BH3 domain) | |
CDH13 | CDH13 | cadherin 13 | |
ESR1 | ESR1 | estrogen receptor 1 |